Market Tracker

08/24 4:26am ET

Becton Dickinson and Co (NYSE:BDX)

174.91
Delayed Data
As of Aug 23
 +0.45 / +0.26%
Today’s Change
128.87
Today|||52-Week Range
177.78
+13.51%
Year-to-Date
Medtronic Launches MiniMed 630G, Expands in Diabetic Care (revised)
Aug 15 / Zacks.com - Paid Partner Content
Top 4 Research Reports for August 11, 2016
Aug 11 / Zacks.com - Paid Partner Content
Medtronic Launches MiniMed 630G, Expands in Diabetic Care
Aug 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close174.46
Today’s open174.75
Day’s range174.71 - 176.00
Volume688,449
Average volume (3 months)898,176
Market cap$37.1B
Dividend yield1.51%
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.65%
Earnings growth (next 5 years)+11.15%
Revenue growth (last year)+21.94%
P/E ratio33.4
Price/Sales2.68
Price/Book5.13

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...-0.01-0.04%
ZBHZimmer Biomet Holdin...+1.51+1.18%
BCRC R Bard Inc-0.29-0.13%
TFXTeleflex Inc-0.29-0.16%
Data as of 08/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$2.10
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
EVP, Chief Financial &
Administrative Officer
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts